Acadia Healthcare (ACHC) to Release Quarterly Earnings on Wednesday

Key Points

• Acadia Healthcare will report its Q1 2026 results after the market close on April 29; analysts expect about $0.28 EPS and $822.9M in revenue, and the company has guided FY2026 EPS of $1.30–$1.55 with Q1 guidance of $0.25–$0.30.
• In the prior quarter (reported Feb. 25) Acadia posted $0.07 EPS on $821.5M revenue (up 6.1% YoY) but reported a negative net margin of 33.29%; analysts project roughly $1 EPS for the current fiscal year and $2 for next year.
• Market sentiment is mixed with a consensus “Hold” rating (average target $22.19) even as major institutions like Goldman Sachs and Wellington substantially increased their stakes.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) is anticipated to announce its Q1 2026 results after the market closes on Wednesday, April 29th. Analysts expect the company to announce earnings of $0.28 per share and revenue of $822.8930 million for the quarter. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Investors may review the information on the company's upcoming Q1 2026 earning report for the latest details on the call scheduled for Thursday, April 30, 2026 at 9:00 AM ET.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The firm had revenue of $821.46 million during the quarter, compared to analyst estimates of $800.10 million. During the same period last year, the business earned $0.64 earnings per share. The business's revenue was up 6.1% on a year-over-year basis. On average, analysts expect Acadia Healthcare to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Acadia Healthcare Price Performance

ACHC stock opened at $27.44 on Wednesday. The firm has a market capitalization of $2.53 billion, a price-to-earnings ratio of -2.25, a PEG ratio of 9.41 and a beta of 0.71. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.55 and a current ratio of 1.55. The firm has a 50 day moving average price of $22.88 and a 200-day moving average price of $19.02. Acadia Healthcare has a 52-week low of $11.43 and a 52-week high of $28.48.

Analyst Ratings Changes

ACHC has been the subject of several analyst reports. Jefferies Financial Group reissued a "hold" rating and set a $24.50 price target on shares of Acadia Healthcare in a research report on Monday. Zacks Research raised shares of Acadia Healthcare from a "strong sell" rating to a "hold" rating in a research report on Thursday, March 5th. Weiss Ratings reissued a "sell (d)" rating on shares of Acadia Healthcare in a research report on Wednesday, January 21st. Royal Bank Of Canada raised their price target on shares of Acadia Healthcare from $17.00 to $28.00 and gave the company an "outperform" rating in a research report on Thursday, February 26th. Finally, TD Cowen raised their price target on shares of Acadia Healthcare from $22.00 to $24.00 and gave the company a "buy" rating in a research report on Thursday, February 26th. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $22.19.

Institutional Investors Weigh In On Acadia Healthcare

A number of large investors have recently added to or reduced their stakes in ACHC. Goldman Sachs Group Inc. grew its position in Acadia Healthcare by 417.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company's stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the period. Wellington Management Group LLP grew its position in Acadia Healthcare by 24.9% in the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company's stock worth $167,077,000 after purchasing an additional 2,350,760 shares during the period. Deerfield Management Company L.P. bought a new stake in Acadia Healthcare in the 3rd quarter worth approximately $29,440,000. Rubric Capital Management LP bought a new stake in Acadia Healthcare in the 3rd quarter worth approximately $27,236,000. Finally, Capitolis Liquid Global Markets LLC bought a new stake in Acadia Healthcare in the 4th quarter worth approximately $8,954,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.